Mortgage Blog Kineta inks $520 million Pfizer deal to develop cancer immunotherapy drugs firststargroup December 22, 2018 The Seattle-based biotech struck a non-opioid drug collaboration agreement earlier this year worth up to $359 million.
The Seattle-based biotech struck a non-opioid drug collaboration agreement earlier this year worth up to $359 million.
